Meanwhile, World Courier remains up for bid, possibly to be acquired by FedEx
Marken (London, US HQ in Uniondale, NY), a leading provider of clinical trial logistics, has received a “expanded” business license to allow the storage and distribution of clinical trial materials (CTMs) in China, where it already has a courier business. Also within recent weeks, it has organized a competency center around cold chain services (for both clinical and commercial logistics), hired a QA manager for its Berlin office, and promoted the availability of two IT systems (Solo, a tracking and planning system, and Maestro, a client web portal). And it has ambitious growth plans: "We have an aggressive plan to build six more purpose-built pharmaceutical service depots this year," said Frank Wright, president, clinical trials distribution, in a press release. "With the completion of Argentina and the start of Beijing, we are off to a strong start in 2012. We have engaged a global engineering and construction firm to assist us and ensure that the standards of construction are up to the highest standards in the industry."
Meanwhile, there continue to be press reports of an on-again, off-again negotiation for selling World Courier, another major CTMs courier service. Earlier press reports had said that UPS had looked at, but then passed on, acquiring the New Hyde Park, NY company; now FedEx is rumored to be at the bargaining table.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.